Sammenlign metoder
Gjennomgå de valgte metodene side om side; rader som avviker, er uthevet.
| Frontal Assessment Battery× | Addenbrooke's kognitive undersøkelse× | |
|---|---|---|
| Fagfelt | Nevropsykologi | Nevropsykologi |
| Familie | Process / pipeline | Process / pipeline |
| Opprinnelsesår | 2000 | 2000 |
| Opphavsperson≠ | Bruno Dubois | Padasalai Mathuranath |
| Type≠ | Clinician-administered neuropsychological battery for frontal lobe function | Clinician-administered comprehensive cognitive examination |
| Opprinnelig kilde≠ | Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626. DOI ↗ | Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620. DOI ↗ |
| Alias≠ | FAB, Frontal Battery | ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination |
| Relaterte | 5 | 5 |
| Sammendrag≠ | The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function. | The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia. |
| ScholarGateDatasett ↗ |
|
|